-- Asymchem Laboratories (HKG:6821, SHE:002821) posted a net profit attributable to shareholders of 1.13 billion yuan for 2025, up 19% from 949.0 million yuan a year earlier, according to a Monday Hong Kong bourse filing.
Hong Kong-listed shares of the pharmaceutical outsourcing services firm lost nearly 2% in Tuesday morning trade.
Earnings per share came in at 3.16 yuan, compared with 2.69 yuan in the prior year.
Revenue rose 15% to 6.67 billion yuan from 5.80 billion yuan in 2024.
The board proposed a final dividend of 13 yuan per 10 shares.